Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
about
Original insights on thrombospondin-1-related antireceptor strategies in cancer.Thrombospondin immune regulation and the kidney.Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide.Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma.
P2860
Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
@ast
Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
@en
type
label
Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
@ast
Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
@en
prefLabel
Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
@ast
Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
@en
P2093
P2860
P50
P356
P1433
P1476
Identification of TAX2 peptide as a new unpredicted anti-cancer agent
@en
P2093
Albin Jeanne
Emilie Sick
Jérôme Devy
Laurent Martiny
Louis Theret
Manuel Dauchez
Marie-Danièle Diebold
Nicolas Belloy
Nicolas Floquet
P2860
P304
17981-18000
P356
10.18632/ONCOTARGET.4025
P407
P577
2015-07-01T00:00:00Z